Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Development and validation of a nomogram to predict overall survival in young non-metastatic rectal-cancer patients after curative resection: A Population-Based Analysis

View through CrossRef
Abstract Purpose: This study was aimed to establish and validate a nomogram for predicting overall survival (OS) in young non-metastatic rectal-cancer (RC) patients after curative resection.Methods: Young RC patients (under 50 years of age) from 2010 to 2015 were extracted from the surveillance, epidemiology and results (SEER) database. Those patients randomly assigned to a training cohort and a validation cohort at a ratio of 7:3. The independent prognostic factors for OS were identified by univariate and multivariate Cox regression analysis. A nomogram model was built based on the independent prognostic variables and was evaluated by concordance index (C-index), receiver operating characteristics (ROC) curves, calibration plot and decision curve analysis (DCA).Results: A total number of 3026 young RC patients were extracted from SEER database. OS nomogram was constructed based on race, histological type, tumor grade, T stage, N stage, carcinoembryonic antigen (CEA) level, and number of lymph nodes (LN) examined. C-index, ROC curves, calibration plot and DCA curves presented satisfactory performance of the above nomogram in predicting the prognosis of young non-metastatic RC patients after curative resection. The nomogram can identify three subgroups of patients at different risks, which showed different prognostic outcomes both in the training cohort and validation cohort.Conclusion: We successfully established a reliable and insightful nomogram to predict OS for young non-metastatic RC patients after curative resection. The nomogram may provide accurate prognosis prediction to guide individualized follow-up and treatment plans.
Title: Development and validation of a nomogram to predict overall survival in young non-metastatic rectal-cancer patients after curative resection: A Population-Based Analysis
Description:
Abstract Purpose: This study was aimed to establish and validate a nomogram for predicting overall survival (OS) in young non-metastatic rectal-cancer (RC) patients after curative resection.
Methods: Young RC patients (under 50 years of age) from 2010 to 2015 were extracted from the surveillance, epidemiology and results (SEER) database.
Those patients randomly assigned to a training cohort and a validation cohort at a ratio of 7:3.
The independent prognostic factors for OS were identified by univariate and multivariate Cox regression analysis.
A nomogram model was built based on the independent prognostic variables and was evaluated by concordance index (C-index), receiver operating characteristics (ROC) curves, calibration plot and decision curve analysis (DCA).
Results: A total number of 3026 young RC patients were extracted from SEER database.
OS nomogram was constructed based on race, histological type, tumor grade, T stage, N stage, carcinoembryonic antigen (CEA) level, and number of lymph nodes (LN) examined.
C-index, ROC curves, calibration plot and DCA curves presented satisfactory performance of the above nomogram in predicting the prognosis of young non-metastatic RC patients after curative resection.
The nomogram can identify three subgroups of patients at different risks, which showed different prognostic outcomes both in the training cohort and validation cohort.
Conclusion: We successfully established a reliable and insightful nomogram to predict OS for young non-metastatic RC patients after curative resection.
The nomogram may provide accurate prognosis prediction to guide individualized follow-up and treatment plans.

Related Results

Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
A specific nomogram to predict subsequent brain metastasis in metastatic triple-negative breast cancer patients
A specific nomogram to predict subsequent brain metastasis in metastatic triple-negative breast cancer patients
1028 Background: The development of brain metastases is usually a fatal event in the history of breast cancer patients with metastatic disease other than brain (MDOB). We previous...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...
Metastatic colorectal cancer from an epidemiological and immunological perspective
Metastatic colorectal cancer from an epidemiological and immunological perspective
<p dir="ltr">Colorectal cancer (CRC) is the third most common type of cancer and around 8000 persons in Sweden get the diagnosis each year. One in five will have metastases a...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...

Back to Top